Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Lupus Science & Medicine|February 3, 2016
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study resultsCecile M Yelnik, Carl A Laskin, T Flint Porter, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy OutcomesCecile M Yelnik, T Flint Porter, D Ware Branch, et al.
Annals of the Rheumatic Diseases|January 27, 2018
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodiesMimi Y Kim, Marta M Guerra, Elianna Kaplowitz, et al.
Thrombosis Research|November 28, 2017
Variants in chondroitin sulfate metabolism genes in thrombotic stormKaren Nuytemans, Thomas L Ortel, Lissette Gomez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid AntibodiesCecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 13, 2017
Kidney Outcomes and Risk Factors for Nephritis (Flare/<i>De Novo</i>) in a Multiethnic Cohort of Pregnant Patients with LupusJill P Buyon, Mimi Y Kim, Marta M Guerra, et al.
American Journal of Obstetrics and Gynecology|October 4, 2015
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE studyMimi Y Kim, Jill P Buyon, Marta M Guerra, et al.
Pageof 18